Literature DB >> 30568041

OX40L/OX40 axis impairs follicular and natural Treg function in human SLE.

Clément Jacquemin1, Jean-François Augusto2, Marc Scherlinger2,3, Noémie Gensous2, Edouard Forcade2, Isabelle Douchet2, Emeline Levionnois2, Christophe Richez2,3, Estibaliz Lazaro2,3, Pierre Duffau2,3, Marie-Elise Truchetet2,3, Julien Seneschal1,3, Lionel Couzi3, Jean-Luc Pellegrin3, Jean-François Viallard3, Thierry Schaeverbeke3, Virginia Pascual4, Cécile Contin-Bordes2,3, Patrick Blanco2,3.   

Abstract

Tregs are impaired in human systemic lupus erythematosus (SLE) and contribute to effector T cell activation. However, the mechanisms responsible for the Treg deficiency in SLE remain unclear. We hypothesized that the OX40L/OX40 axis is implicated in Treg and regulatory follicular helper T (Tfr) cell dysfunction in human SLE. OX40L/OX40 axis engagement on Tregs and Tfr cells not only specifically impaired their ability to regulate effector T cell proliferation, but also their ability to suppress T follicular helper (Tfh) cell-dependent B cell activation and immunoglobulin secretion. Antigen-presenting cells from patients with active SLE mediated Treg dysfunction in an OX40L-dependent manner, and OX40L-expressing cells colocalized with Foxp3+ cells in active SLE skin lesions. Engagement of the OX40L/OX40 axis resulted in Foxp3 downregulation in Tregs, and expression in SLE Tregs correlated with the proportion of circulating OX40L-expressing myeloid DCs. These data support that OX40L/OX40 signals are implicated in Treg dysfunction in human SLE. Thus, blocking the OX40L/OX40 axis appears to be a promising therapeutic strategy.

Entities:  

Keywords:  Autoimmune diseases; Autoimmunity; Cellular immune response; Immunology; Lupus

Mesh:

Substances:

Year:  2018        PMID: 30568041      PMCID: PMC6338386          DOI: 10.1172/jci.insight.122167

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  34 in total

Review 1.  Systemic lupus erythematosus.

Authors:  George C Tsokos
Journal:  N Engl J Med       Date:  2011-12-01       Impact factor: 91.245

2.  Antibodies targeting human OX40 expand effector T cells and block inducible and natural regulatory T cell function.

Authors:  Kui S Voo; Laura Bover; Megan L Harline; Long T Vien; Valeria Facchinetti; Kazuhiko Arima; Larry W Kwak; Yong J Liu
Journal:  J Immunol       Date:  2013-09-06       Impact factor: 5.422

3.  Global natural regulatory T cell depletion in active systemic lupus erythematosus.

Authors:  Makoto Miyara; Zahir Amoura; Christophe Parizot; Cécile Badoual; Karim Dorgham; Salim Trad; Dominique Nochy; Patrice Debré; Jean-Charles Piette; Guy Gorochov
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

4.  OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response.

Authors:  Clément Jacquemin; Nathalie Schmitt; Cécile Contin-Bordes; Yang Liu; Priya Narayanan; Julien Seneschal; Typhanie Maurouard; David Dougall; Emily Spence Davizon; Hélène Dumortier; Isabelle Douchet; Loïc Raffray; Christophe Richez; Estibaliz Lazaro; Pierre Duffau; Marie-Elise Truchetet; Liliane Khoryati; Patrick Mercié; Lionel Couzi; Pierre Merville; Thierry Schaeverbeke; Jean-François Viallard; Jean-Luc Pellegrin; Jean-François Moreau; Sylviane Muller; Sandy Zurawski; Robert L Coffman; Virginia Pascual; Hideki Ueno; Patrick Blanco
Journal:  Immunity       Date:  2015-06-09       Impact factor: 31.745

Review 5.  Regulatory T cells in systemic lupus erythematosus.

Authors:  Kim Ohl; Klaus Tenbrock
Journal:  Eur J Immunol       Date:  2014-12-15       Impact factor: 5.532

6.  Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells.

Authors:  Kenneth J Scalapino; Qizhi Tang; Jeffrey A Bluestone; Mark L Bonyhadi; David I Daikh
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

7.  Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus.

Authors:  Jens Y Humrich; Henner Morbach; Reinmar Undeutsch; Philipp Enghard; Stefan Rosenberger; Olivia Weigert; Lutz Kloke; Juliane Heimann; Timo Gaber; Susan Brandenburg; Alexander Scheffold; Jochen Huehn; Andreas Radbruch; Gerd-Rüdiger Burmester; Gabriela Riemekasten
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

8.  OX40L/Jagged1 cosignaling by GM-CSF-induced bone marrow-derived dendritic cells is required for the expansion of functional regulatory T cells.

Authors:  Anupama Gopisetty; Palash Bhattacharya; Christine Haddad; Joseph C Bruno; Chenthamarakshan Vasu; Lucio Miele; Bellur S Prabhakar
Journal:  J Immunol       Date:  2013-04-29       Impact factor: 5.422

9.  Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions.

Authors:  Yeonseok Chung; Shinya Tanaka; Fuliang Chu; Roza I Nurieva; Gustavo J Martinez; Seema Rawal; Yi-Hong Wang; Hoyong Lim; Joseph M Reynolds; Xiao-hui Zhou; Hui-min Fan; Zhong-ming Liu; Sattva S Neelapu; Chen Dong
Journal:  Nat Med       Date:  2011-07-24       Impact factor: 53.440

10.  Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo.

Authors:  Xuyu Zhou; Samantha L Bailey-Bucktrout; Lukas T Jeker; Cristina Penaranda; Marc Martínez-Llordella; Meredith Ashby; Maki Nakayama; Wendy Rosenthal; Jeffrey A Bluestone
Journal:  Nat Immunol       Date:  2009-07-26       Impact factor: 25.606

View more
  15 in total

Review 1.  Cytokines and costimulation in acute graft-versus-host disease.

Authors:  Geoffrey R Hill; Motoko Koyama
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

Review 2.  Treg cells in autoimmunity: from identification to Treg-based therapies.

Authors:  Lisa Göschl; Clemens Scheinecker; Michael Bonelli
Journal:  Semin Immunopathol       Date:  2019-04-05       Impact factor: 9.623

Review 3.  Autoimmunity and organ damage in systemic lupus erythematosus.

Authors:  George C Tsokos
Journal:  Nat Immunol       Date:  2020-05-04       Impact factor: 25.606

4.  Altered Balance of Pro-Inflammatory Immune Cells to T Regulatory Cells Differentiates Symptomatic From Asymptomatic Individuals With Anti-Nuclear Antibodies.

Authors:  Rashi Gupta; Emma Vanlieshout; Kieran Manion; Dennisse Bonilla; Michael Kim; Carolina Muñoz-Grajales; Carol Nassar; Sindhu R Johnson; Linda T Hiraki; Zareen Ahmad; Zahi Touma; Arthur Bookman; Joan E Wither
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

5.  Hsa_circ_0000652 Aggravates Inflammation by Activation of Macrophages and Enhancement of OX40/OX40L Interaction in Ankylosing Spondylitis.

Authors:  Minkai Song; Jiawen Gao; Tao Yan; Enguang Bi; Taixue An; Xiangyu Wang; Weizhou Jiang; Ting Wang; Zishuo Chen; Zhanjun Shi; Chao Zhang; Jun Xiao
Journal:  Front Cell Dev Biol       Date:  2021-12-16

6.  CD4+ T Cells Promote IgG Production in MHC-Independent and ICAM-1-Dependent Manners in Pristane-Induced Lupus Mice.

Authors:  Shuai Liu; Yu-Mei Li; Jin-Zhi Li; Shu-Jun Wang; Ping Ji; Mei-Yu Zhang; Ying Wang
Journal:  Mediators Inflamm       Date:  2022-01-21       Impact factor: 4.711

7.  Impaired function of PD-1+ follicular regulatory T cells in systemic lupus erythematosus.

Authors:  Izumi Kurata; Natsuko Mikami; Ayako Ohyama; Atsumu Osada; Yuya Kondo; Hiroto Tsuboi; Takayuki Sumida; Isao Matsumoto
Journal:  Clin Exp Immunol       Date:  2021-07-21       Impact factor: 5.732

8.  Decitabine attenuates dextran sodium sulfate‑induced ulcerative colitis through regulation of immune regulatory cells and intestinal barrier.

Authors:  Chang Su; Shaoqun Liu; Xiaoying Ma; Xiaotong Yang; Jianwen Liu; Peiyong Zheng; Yiou Cao
Journal:  Int J Mol Med       Date:  2020-05-18       Impact factor: 4.101

Review 9.  Follicular regulatory T cells: a novel target for immunotherapy?

Authors:  Yao Huang; Zhe Chen; Hui Wang; Xin Ba; Pan Shen; Weiji Lin; Yu Wang; Kai Qin; Ying Huang; Shenghao Tu
Journal:  Clin Transl Immunology       Date:  2020-02-14

10.  Dendritic Cells and Microglia Have Non-redundant Functions in the Inflamed Brain with Protective Effects of Type 1 cDCs.

Authors:  Mattia Gallizioli; Francesc Miró-Mur; Amaia Otxoa-de-Amezaga; Roger Cugota; Angélica Salas-Perdomo; Carles Justicia; Vanessa H Brait; Francisca Ruiz-Jaén; Maria Arbaizar-Rovirosa; Jordi Pedragosa; Ester Bonfill-Teixidor; Mathias Gelderblom; Tim Magnus; Eva Cano; Carlos Del Fresno; David Sancho; Anna M Planas
Journal:  Cell Rep       Date:  2020-10-20       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.